Organization · Venture Capital
NCL Investment Management
NCL Investment Management is a UK-based venture capital firm specializing in healthcare investments. Founded in 2015, it focuses on early-stage companies leveraging innovation and technology to modernize healthcare.
Overview
What NCL Investment Management does
What NCL Investment Management is
NCL Investment Management is a UK-based venture capital firm specializing in healthcare investments. Founded in 2015, it focuses on early-stage companies leveraging innovation and technology to modernize healthcare.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- March 30, 2026
Official channels
Find NCL Investment Management elsewhere
Open the official website or a supported primary organization account.
Capability profile
NCL Investment Management as a funder
Investment thesis
The Modernisation of Healthcare will be one of the Greatest Growth Drivers of the 21st Century.
Focus narrative
NCL Investment Management invests in companies that leverage innovation and technology to address a wide range of health conditions. Their investment strategy emphasizes supporting early-stage ventures that are pioneering advancements in healthcare technology, medtech, biotech, digital health, and therapeutics.
Value beyond capital
NCL Investment Management provides hands-on support to its portfolio companies, assisting them through clinical trials, regulatory approvals, reimbursement strategies, and market access. Their team combines deep industry expertise with a strong scientific background to ensure that investments are well-positioned for success in the healthcare market.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+
- Regions
- EuropeUnited Kingdom
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 9
- Recorded notable exits
- TC Biopharm
Portfolio context
Notable portfolio companies include: Ampersand Health (digital health for chronic inflammatory disease), Azadyne (CNS/neurology therapeutics), Centauri Therapeutics (immunotherapy platform), Curesponse (AI-driven personalized oncology treatment), Emteq Labs (facial EMG wearable for emotion analytics/mental health), Revolo (GABA pathway therapeutics for CNS disorders), Sana Health (neuromodulation for chronic pain), TC Biopharm (gamma delta T cell therapy for oncology), and Viramel (antiviral therapeutics).
Common questions
What to know about NCL Investment Management
Upseed classifies NCL Investment Management under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.